Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
O02757
|
T-cell-specific surface glycoprotein CD28; CD antigen CD28;
|
CD28;
|
NULL
|
221
|
cat
|
Q5R1Q1
|
T-cell surface glycoprotein CD3 epsilon chain; CD antigen CD3e;
|
CD3E;
|
NP_001009862.1;
|
202
|
cat
|
O97605
|
CD40 ligand; CD40-L; Tumor necrosis factor ligand superfamily member 5; CD antigen CD154; [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form];
|
CD40LG; CD40L TNFSF5;
|
NP_001009298.1;
|
260
|
cat
|
Q76B49
|
CD63 antigen; CD antigen CD63;
|
CD63;
|
NP_001009855.1;
|
238
|
cat
|
P41688
|
T-cell surface glycoprotein CD8 alpha chain; CD antigen CD8a;
|
CD8A;
|
NP_001009843.1;
|
239
|
cat
|
P79336
|
T-cell surface glycoprotein CD8 beta chain; CD antigen CD8b;
|
CD8B; CD8B1;
|
NP_001009867.1;
|
210
|
cat
|
P40239
|
CD9 antigen; CD antigen CD9;
|
CD9;
|
NP_001009305.1;
|
226
|
cat
|
O19002
|
Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; p21;
|
CDKN1A; CIP1 WAF1;
|
NP_001009865.1;XP_006931683.1;
|
164
|
cat
|
O19001
|
Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; p27Kip1;
|
CDKN1B; KIP1;
|
NP_001009870.1;
|
198
|
cat
|
Q5R1M5
|
Chymotrypsin-like elastase family member 1; EC 3.4.21.36; Elastase-1;
|
CELA1; ELA1 ELS1;
|
NP_001009389.1;
|
266
|
cat
|
O62760
|
Cholinesterase; EC 3.1.1.8; Acylcholine acylhydrolase; Butyrylcholine esterase; Choline esterase II; Pseudocholinesterase;
|
BCHE;
|
NP_001009364.1;
|
602
|
cat
|
P09873
|
Chymosin; EC 3.4.23.4; Fragment;
|
CYM;
|
NULL
|
54
|
cat
|
O02777
|
Cannabinoid receptor 1; CB-R; CB1;
|
CNR1;
|
NP_001009331.1;
|
472
|
cat
|
P61248
|
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma; GMP-PDE gamma; EC 3.1.4.35;
|
PDE6G; PDEG;
|
XP_003997317.1;
|
87
|
cat
|
P48888
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1; Cytochrome c oxidase polypeptide I;
|
MT-CO1; COI COXI MTCO1;
|
NP_008253.1;
|
514
|
cat
|
P48890
|
Cytochrome c oxidase subunit 2; Cytochrome c oxidase polypeptide II;
|
MT-CO2; COII COXII MTCO2;
|
NP_008254.1;
|
227
|
cat
|
P48892
|
Cytochrome c oxidase subunit 3; Cytochrome c oxidase polypeptide III;
|
MT-CO3; COIII COXIII MTCO3;
|
NP_008257.1;
|
261
|
cat
|
Q9GMC8
|
Steroid 17-alpha-hydroxylase/17,20 lyase; EC 1.14.99.9; EC 4.1.2.30; 17-alpha-hydroxyprogesterone aldolase; CYPXVII; Cytochrome P450 17A1; Cytochrome P450-C17; Cytochrome P450c17;
|
CYP17A1; CYP17;
|
NP_001009371.1;
|
508
|
cat
|
Q5KQT7
|
Cytochrome P450 1A1; EC 1.14.14.1; CYPIA1;
|
CYP1A1;
|
NP_001020030.1;
|
517
|
cat
|
Q5KQT6
|
Cytochrome P450 1A2; EC 1.14.14.1; CYPIA2;
|
CYP1A2;
|
NP_001041478.1;
|
512
|
cat
|